Literature DB >> 24210601

Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece.

I Stefanidis1, A Vainas, E Dardiotis, C D Giannaki, P Gourli, D Papadopoulou, P Vakianis, E Patsidis, T Eleftheriadis, V Liakopoulos, S Pournaras, G K Sakkas, E Zintzaras, G M Hadjigeorgiou.   

Abstract

BACKGROUND: Restless legs syndrome (RLS) is a sensorimotor disorder characterized by an uncontrolled need to move extremities accompanied by unpleasant sensations, which frequently leads to sleep disturbances. In hemodialysis (HD) patients, the previously reported RLS prevalence varied enormously, between 6% and 60%. In our study, we investigated the RLS prevalence in HD patients for the first time in Greece.
METHODS: A continuous sample of HD patients was studied between January and September of 2010 in six dialysis units in Greece. RLS diagnosis was based on the essential clinical criteria of the International RLS Study Group (IRLSSG). The standardized incidence ratio (SIR) for RLS in HD patients was calculated in comparison to data from a recent survey of the general population in Greece.
RESULTS: In our study of 579 HD patients in Greece (236 women; mean age, 65±13years), the prevalence of RLS was elevated in comparison to the general population (26.6% vs 3.9%), with an SIR of 5.4 (95% confidence interval [CI], 4.6-6.3). In the fully adjusted model, the risk for RLS in HD patients was reduced in older age (odds ratio [OR], 0.98 [95% CI, 0.96-0.99]) and increased in women (OR, 1.60 [95% CI, 1.05-2.43]) in cases with elevated levels of β2 microglobulin (OR, 1.15 [95% CI, 1.01-1.32]) and intact parathormone (iPTH) (OR, 1.30 [95% CI, 1.08-1.56]).
CONCLUSION: A high RLS prevalence was recorded in a large HD population in Greece, clearly suggesting the need for enhanced awareness of RLS in nephrology. The RLS risk was increased in women and in younger HD patients as well as in those with elevated β2 microglobulin and iPTH levels.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Chronic kidney disease; End-stage renal disease; Epidemiological study; Hemodialysis; Iron deficiency; Restless legs syndrome

Mesh:

Substances:

Year:  2013        PMID: 24210601     DOI: 10.1016/j.sleep.2013.05.022

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  14 in total

1.  Restless legs syndrome/Willis-Ekbom disease prevalence in beta thalassemia patients.

Authors:  Euthimia Dimitriadou; Christoforos D Giannaki; Maria Tsekoura; Ioannis Stefanidis; Georgios M Hadjigeorgiou; Eleftherios Lavdas; Christina Karatzaferi; Giorgos K Sakkas
Journal:  Sleep Breath       Date:  2017-04-19       Impact factor: 2.816

2.  Restless legs syndrome in maintenance hemodialysis patients: an epidemiologic survey in Hefei.

Authors:  Jian-Ping Xiao; Gui-Xia Zhang; Lei Chen; Ben-Gui Sun; Hong-Xu Zhang; Li-Hong Chen; Liang Yuan; Li Hao; De-Guang Wang
Journal:  Int Urol Nephrol       Date:  2017-03-28       Impact factor: 2.370

3.  Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India.

Authors:  Amit Goel; Shankar Lal Jat; Avani Sasi; Vimal Kumar Paliwal; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2016-05-26

4.  Restless legs syndrome among Saudi end-stage renal disease patients on hemodialysis.

Authors:  Siraj O Wali; Abeer F Alkhouli
Journal:  Saudi Med J       Date:  2015-02       Impact factor: 1.484

Review 5.  The Prevalence of Restless Legs Syndrome in Patients Undergoing Hemodialysis: A Systematic Review and Meta-analysis Study.

Authors:  Reza Ghanei Gheshlagh; Mohammad Farajzadeh; Mozhdeh Zarei; Vajiheh Baghi; Sahar Dalvand; Kourosh Sayehmiri
Journal:  Basic Clin Neurosci       Date:  2017 Mar-Apr

6.  Restless leg syndrome a common undiagnosed comorbidity of clinical significance in cirrhosis.

Authors:  Akash Rajender; Saumya Mathur; Priyanka Choudhary; Shalini Upadhyay; Gaurav Rajender; Rajat Bhargava; Subhash Nepalia
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019

7.  Reporting Quality of Randomized Controlled Trials in Restless Legs Syndrome Based on the CONSORT Statement.

Authors:  Dimitrios Rikos; Efthimios Dardiotis; Athina-Maria Aloizou; Vasileios Siokas; Elias Zintzaras; Georgios M Hadjigeorgiou
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-06-18

8.  Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis.

Authors:  Roberto Sávio Silva Santos; Fernando Morgadinho Santos Coelho; Bruno Caldin da Silva; Fabiana Giorgeti Graciolli; Wagner Velasquez Dominguez; Fabio Luiz de Menezes Montenegro; Vanda Jorgetti; Rosa Maria Affonso Moysés; Rosilene Motta Elias
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

9.  The association between the prevalence of restless leg syndrome, fatigue, and sleep quality in patients undergoing hemodialysis.

Authors:  Ayla C Turk; Sultan Ozkurt; Ebru Turgal; Fusun Sahin
Journal:  Saudi Med J       Date:  2018-08       Impact factor: 1.484

10.  Restless Leg Syndrome in Peripheral Artery Disease: Prevalence among Patients with Claudication and Benefits from Low-Intensity Exercise.

Authors:  Nicola Lamberti; Pablo Jesús López-Soto; María Aurora Rodríguez-Borrego; Sofia Straudi; Nino Basaglia; Paolo Zamboni; Roberto Manfredini; Fabio Manfredini
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.